The Medical Journal of Australia

Estimating Eligibility for GLP-1 Receptor Agonists for Chronic Weight Management and Cardiovascular Disease in Australia: Cross-Sectional Analysis of National Health Survey Data

By Jasmin Elkin, Chris G. Schilling, Sharmala Thuraisingam, Cade Shadbolt

Study in peoplePopulations

The paper

Jasmin Elkin, Chris G. Schilling, Sharmala Thuraisingam, Cade Shadbolt

The University of Melbourne

The Medical Journal of Australia, 1 Aug 2026

doi.org/10.5694/mja2.70253 PubMed 42604458

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety